Butler, P. C. (2016). Glucagon-Like Peptide 1 Drugs as Second-Line Therapy for Type 2 Diabetes. JAMA Intern Med.
Παραπομπή Chicago StyleButler, Peter C. "Glucagon-Like Peptide 1 Drugs As Second-Line Therapy for Type 2 Diabetes." JAMA Intern Med 2016.
Παραπομπή MLAButler, Peter C. "Glucagon-Like Peptide 1 Drugs As Second-Line Therapy for Type 2 Diabetes." JAMA Intern Med 2016.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.